Wegovy [injectable] for weight management) Tirzepatide (Mounjaro) is a related incretin-based therapy that acts as a dual GIP/GLP-1 receptor agonist
Pharmacology (2002) 65(2):836
"The Medicare GLP-1 Bridge changes that by making these medications more affordable and accessible, while advancing our broader goal of helping Americans live healthier lives." GLP-1 drugs, which include medications like Wegovy, Foundayo, and Zepbound, were originally developed to treat Type 2 diabetes but are now widely prescribed for weight loss and related health conditions
Those who participate in a vegan or vegetarian diet most commonly suffer from a B-12 deficiency due to it only being found in animal-based foods
Whether delivered as an injection or an oral pill, semaglutide mimics the GLP-1 hormone to curb appetite, fostering sustainable weight loss
Immunogenicity: Patients may develop antibodies to insulin and lixisenatide